Coherent Stock Price, News & Analysis (NASDAQ:COHR)

Coherent trades on the NASDAQ under the ticker symbol "COHR."

Coherent declared that its board has approved a share repurchase program on Thursday, February 8th 2018, which permits the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued.

Coherent, Inc. (NASDAQ:COHR) announced its quarterly earnings data on Tuesday, July, 30th. The scientific and technical instruments company reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.05 by $0.28. The scientific and technical instruments company had revenue of $339.17 million for the quarter, compared to analyst estimates of $348.61 million. Coherent had a return on equity of 13.38% and a net margin of 8.12%. Coherent's quarterly revenue was down 29.7% on a year-over-year basis. During the same period last year, the company posted $3.51 EPS. View Coherent's Earnings History.

Coherent is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Coherent.

10 brokerages have issued 12 month target prices for Coherent's shares. Their forecasts range from $125.00 to $175.00. On average, they expect Coherent's stock price to reach $150.00 in the next twelve months. This suggests that the stock has a possible downside of 0.9%. View Analyst Price Targets for Coherent.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Coherent in the last year. There are currently 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Coherent.

Press coverage about COHR stock has trended negative recently, InfoTrie reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Coherent earned a news impact score of -2.9 on InfoTrie's scale. They also assigned news stories about the scientific and technical instruments company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Coherent.

Coherent saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 1,750,400 shares, an increase of 14.0% from the July 31st total of 1,535,200 shares. Based on an average daily trading volume, of 321,000 shares, the short-interest ratio is presently 5.5 days. Currently, 7.4% of the shares of the stock are sold short. View Coherent's Current Options Chain.

Some companies that are related to Coherent include Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), PerkinElmer (PKI), Avantor (AVTR), Bruker (BRKR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM), Arrayit (ARYC) and Precipio (PRPO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Coherent investors own include NVIDIA (NVDA), Alibaba Group (BABA), Lam Research (LRCX), Adobe (ADBE), Micron Technology (MU), Broadcom (AVGO), Netflix (NFLX), Paypal (PYPL), NetEase (NTES) and Applied Materials (AMAT).

Coherent's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.34%), BlackRock Inc. (9.27%), BlackRock Inc. (9.27%), Victory Capital Management Inc. (4.98%), Eagle Asset Management Inc. (4.17%) and Invesco Ltd. (2.66%). Company insiders that own Coherent stock include Bret Dimarco, Jay T Flatley, Mark Stewart Sobey, Pamela Fletcher, Paul F Sechrist, Sandeep Vij and Stephen A Skaggs. View Institutional Ownership Trends for Coherent.

COHR stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Point72 Asset Management L.P., Westwood Management Corp IL, Wells Fargo & Company MN, Pictet Asset Management Ltd., First Trust Advisors LP, Bamco Inc. NY and BlackRock Inc.. View Insider Buying and Selling for Coherent.

COHR stock was purchased by a variety of institutional investors in the last quarter, including Invesco Ltd., DekaBank Deutsche Girozentrale, Westfield Capital Management Co. LP, Victory Capital Management Inc., State of New Jersey Common Pension Fund D, Minneapolis Portfolio Management Group LLC, Nuveen Asset Management LLC and Bank of America Corp DE. View Insider Buying and Selling for Coherent.

Shares of COHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of COHR stock can currently be purchased for approximately $151.41.

Coherent has a market capitalization of $3.63 billion and generates $1.90 billion in revenue each year. The scientific and technical instruments company earns $247.35 million in net income (profit) each year or $13.04 on an earnings per share basis. Coherent employs 5,418 workers across the globe.View Additional Information About Coherent.

The official website for Coherent is http://www.coherent.com/.

Coherent's mailing address is 5100 Patrick Henry Drive, Santa Clara CA, 95054. The scientific and technical instruments company can be reached via phone at 408-764-4000.